Norges Bank’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $470K | Buy |
+49,319
| New | +$470K | ﹤0.01% | 1634 |
|
|
2025
Q1 | – | Sell |
-950,104
| Closed | -$22.4M | – | 510 |
|
|
2024
Q4 | $22.4M | Buy |
+950,104
| New | +$22.4M | ﹤0.01% | 1214 |
|
|
2024
Q3 | – | Sell |
-107,089
| Closed | -$3.78M | – | 523 |
|
|
2024
Q2 | $3.78M | Buy |
107,089
+59,831
| +127% | +$2.11M | ﹤0.01% | 1616 |
|
|
2024
Q1 | $1.34M | Buy |
+47,258
| New | +$1.34M | ﹤0.01% | 1773 |
|
|
2023
Q3 | – | Sell |
-195,600
| Closed | -$2.2M | – | 1986 |
|
|
2023
Q2 | $2.2M | Sell |
195,600
-168,000
| -46% | -$1.89M | ﹤0.01% | 1862 |
|
|
2023
Q1 | $4.19M | Buy |
363,600
+205,848
| +130% | +$2.37M | ﹤0.01% | 1804 |
|
|
2022
Q4 | $1.83M | Buy |
+157,752
| New | +$1.83M | ﹤0.01% | 1983 |
|
|
2022
Q2 | – | Sell |
-600,000
| Closed | -$5.78M | – | 2089 |
|
|
2022
Q1 | $5.78M | Sell |
600,000
-103,400
| -15% | -$997K | ﹤0.01% | 1843 |
|
|
2021
Q4 | $8.36M | Sell |
703,400
-13,700
| -2% | -$163K | ﹤0.01% | 1810 |
|
|
2021
Q3 | $11.6M | Buy |
717,100
+117,100
| +20% | +$1.9M | ﹤0.01% | 1716 |
|
|
2021
Q2 | $12.6M | Hold |
600,000
| – | – | ﹤0.01% | 1714 |
|
|
2021
Q1 | $9.32M | Buy |
600,000
+200,000
| +50% | +$3.11M | ﹤0.01% | 1802 |
|
|
2020
Q4 | $8.4M | Sell |
400,000
-80,769
| -17% | -$1.7M | ﹤0.01% | 1801 |
|
|
2020
Q3 | $9.71M | Buy |
+480,769
| New | +$9.71M | ﹤0.01% | 1717 |
|